Will you be at Wild On Wounds 2024? Be sure to attend Session 206: From Womb to Wound: A LIVE Dissection and Exploration of Placental Based Allografts. Seats are limited, so reserve your spot today! When? August 15, 2024, 10:20 AM – 11:20 AM Where? Wildflower A Add this session to your existing registration online: https://bit.ly/4brSi9O #MIMEDX #WOW2024 #WoundCare #SkinSubstitutes
About us
MIMEDX is a pioneer and leader in the field of placental tissue. With more than a decade of helping clinicians manage chronic and hard-to-heal wounds, MIMEDX is dedicated to providing a leading portfolio of products for applications in the wound care, burn, and surgical settings of healthcare. The Company's vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life.
- Website
-
http://www.mimedx.com
External link for MiMedx
- Industry
- Medical Equipment Manufacturing
- Company size
- 501-1,000 employees
- Headquarters
- Marietta, Georgia
- Type
- Public Company
- Founded
- 2008
- Specialties
- Biomaterials, Sports Medicine, Orthopedics, Spine, Wound Care, Burn, and Surgical
Locations
-
Primary
1775 West Oak Commons Ct. NE
Marietta, Georgia 30062, US
-
300 Townpark Dr. NW
Kennesaw, Georgia 30144, US
Employees at MiMedx
Updates
-
We were thrilled to have Betsy Grunch, MD, FAANS, FACS, FCNS, a leading neurosurgeon AKA LadySpineDoc, at our recent Strategy & Innovation Summit in Las Vegas! Dr. Grunch shared her expertise on the benefits of harnessing social media as a healthcare provider. Her insights into digital engagement are invaluable for healthcare providers looking to make deeper connections with their patients and peers. Thank you, Dr. Grunch, for your inspiring contribution! The remaining Strategy & Innovation Summit seats are filling up fast. Reserve yours today: https://lnkd.in/eAk7niKt #MIMEDX #HealthcareInnovation #SocialMediaInHealthcare #Neurosurgery #SpineSurgery
-
MIMEDX is excited to announce the expansion of our product portfolio with the commercial launch of HELIOGEN Fibrillar Collagen Matrix. HELIOGEN is a 510(k)-cleared, advanced bovine collagen matrix processed to retain the native triple helical structure of connective tissue. This product is indicated for the management of moderately to heavily exudating wounds and to control minor bleeding. MIMEDX is committed to providing the best products and care for your patients and we are excited to bring HELIOGEN to those who need it most. Read about the launch here: https://bit.ly/3LPJcJC
-
Join the MIMEDX leadership team’s live webcast and discussion of our Q2 2024 operating and financial results this afternoon. Click the link to review the results and webcast details: https://bit.ly/4d1zX51
-
Will you be at Wild On Wounds in August? Be sure to stop by MIMEDX’s booth 505 to learn about our innovative new products designed to help you meet your clinical objectives. Let's go wild on wounds together! #MIMEDX #WOW2024 #WoundCare
-
WoundGenex Premier Graft Program allows you to offer patients the treatment they need without the immediate financial requirement. Use MIMEDX’s advanced allografts now and only pay once you’ve been reimbursed. Interested in learning how to get started? https://bit.ly/3xFGJxk
Our Premier Graft Program has a deferred payment model. Only pay once you've been reimbursed from the payer. Alleviating these financial pressures on healthcare providers, our Graft Program stands as a testament to WoundGenex’s commitment to patient access to high-quality wound care. This model allows healthcare providers to ensure optimal patient outcomes through the use of high-tier skin substitutes without the risk and upfront costs! #woundgenex #woundcare #skinsubstitutes #biologics #woundhealing #diabeticwound #wounds #woundmanagement #premiergraftprogram #clinicaldocumentation #CDI #wound #medicalbilling #medicalbillingservices #medicalbillingcompany #medicalcoding
-
MIMEDX research on human amniotic membrane products was recently published in Nature, Scientific Reports—the 5th most-cited journal in the world. We thank our R&D team for their commitment to advancing the clinical and scientific foundation for the industry’s most widely studied amniotic products on the market. Read the open access article: https://lnkd.in/e66e7ArV #MIMEDX #PressRelease #NatureScientificReports
-
EPIEFFECT® is a tri-layer human placental-based allograft intended for use as a barrier to provide a protective environment to support the healing cascade. EPIEFFECT provides a biocompatible human Extracellular Matrix (ECM) and contains 300+ regulatory proteins¹. Learn more: https://bit.ly/3UFcIYb #MIMEDX #EPIEFFECT #SkinSubstitutes #WoundCare
-
Have you registered for our new clinician portal, MIMEDX Connect? MIMEDX is committed to providing wound care providers with quality service and support. Therefore, we are excited to introduce a more efficient way to place orders, manage insurance verification, and much more so you can get back to focusing on what matters – caring for your patients. Register here: https://bit.ly/3Q2p49F #MIMEDX #MIMEDXConnect #HealthcareInnovation
-
The recent MIMEDX Strategy & Innovation Summit in Henderson, NV, provided a fantastic blend of learning, networking, and fun. Key highlights: - Engaging discussions led by industry experts - Interactive workshops that enhanced practical skills - Cutting-edge educational sessions - Networking opportunities with healthcare providers from diverse specialties Thank you to everyone who attended and contributed to the success of this event. We are grateful for the enthusiasm and insights shared. Are you interested in attending a Summit? Check out the available dates here: https://lnkd.in/eAk7niKt #MIMEDX #InnovationSummit #HealthcareExcellence #PlacentalAllografts #MedicalEducation #WoundCare